Fernandez, Eve F.
HRN: 21-73-23 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/17/2023
10/18/2023
IV
500 Mg
Q8
S/p Primary CS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes